Correlation Between Catalyst Pharmaceuticals and UNITEDHEALTH

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and UNITEDHEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and UNITEDHEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and UNITEDHEALTH GROUP INC, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and UNITEDHEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of UNITEDHEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and UNITEDHEALTH.

Diversification Opportunities for Catalyst Pharmaceuticals and UNITEDHEALTH

-0.21

Correlation Coefficient

Catalyst Pharmaceuticals  UNITEDHEALTH

Very good diversification

The 3 months correlation between Catalyst and UNITEDHEALTH is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and UNITEDHEALTH GROUP INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UNITEDHEALTH GROUP INC and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with UNITEDHEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UNITEDHEALTH GROUP INC has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and UNITEDHEALTH go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and UNITEDHEALTH

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 7.81 times more return on investment than UNITEDHEALTH. However, Catalyst Pharmaceuticals is 7.81 times more volatile than UNITEDHEALTH GROUP INC. It trades about 0.04 of its potential returns per unit of risk. UNITEDHEALTH GROUP INC is currently generating about -0.13 per unit of risk. If you would invest  2,049  in Catalyst Pharmaceuticals on September 21, 2024 and sell it today you would earn a total of  77.00  from holding Catalyst Pharmaceuticals or generate 3.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  UNITEDHEALTH GROUP INC

Catalyst Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

UNITEDHEALTH GROUP INC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days UNITEDHEALTH GROUP INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, UNITEDHEALTH is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Catalyst Pharmaceuticals and UNITEDHEALTH

The main advantage of trading using opposite Catalyst Pharmaceuticals and UNITEDHEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, UNITEDHEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UNITEDHEALTH will offset losses from the drop in UNITEDHEALTH's long position.

The idea behind Catalyst Pharmaceuticals and UNITEDHEALTH GROUP INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.